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Echocardiographic Instrument
and Methodology Used to Detect
and Quantify the Vegetation on
Implantable Electronic Device?
We have read with interest the study by Narducci et al. (1)
comparing transesophageal echocardiography (TEE) and intracar-
diac echocardiography (ICE) for the diagnostic assessment of
cardiac device-related vegetation. Narducci et al. (1) concluded that
ICE provided improved imaging of right-sided leads and increased
the diagnostic yield of identifying attached vegetations compared
with TEE. However, there are several critical questions related to
their instrument, and their methodology needs to be clariﬁed.
What type of ICE equipment was used? The AcuNav ICE
catheter (Siemens Medical Solutions distributed by Biosense
Webster, Diamond Bar, California) using the Sequoia ultrasound
system (Acuson Corporation, Mountain View, California) with
sector phased array transducer and multifrequency (5.5, 7.5, 8.5,
and 10 MHz) has higher imaging resolution and electronic calipers
for distance measurement. The other ICE catheter using the
Cypress ultrasound system (Siemens Medical Solutions)(a simple,
portable type) has a transducer with fewer ultrasonic frequencies
and a lower imaging resolution, as well as limited caliper measuring
capabilities as compared to the Sequoia system. The description
Narducci et al. (1) provided of their ICE instrument is confusing.
In their methods, they describe using a linear (rather than sec-
tor?) “phased array multifrequency (5.5 to 10 MHz) trans-
ducer.connected to a Sequoia system.” In their discussion section,
however, they discuss using a 9 MHz probe: “These results could
be explained by the major resolution power of the intracardiac
probe (9 vs. 5 MHz).” However, the 9 MHz is not an available
option on the AcuNav and Sequoia platform but may be available
with the Cypress ultrasound system. In our experience, ultrasonic
frequency of 9 MHz or 10 MHz is too high to image small
vegetation or thrombus on a device lead in the deep of the right
atrium or right ventricle (>5 cm to 10 cm). In addition, their
2 ICE images (Fig. 1B and Fig. 2C in their article) all show that
Narducci et al. (1) used a Cypress, not Sequoia ultrasound system.
In our experience, the ICE with the Cypress ultrasound system isnot as accurate as the Sequoia, with lower imaging resolution
and limited 2-dimensional and Doppler diagnostic measurement
capabilities as compared to the Sequoia. Therefore, it is important
to point out that using the Cypress ultrasound system to detect and
quantify a small mass or vegetation on cardiac implantable elec-
tronic device leads might not be as sensitive as compared to the
Sequoia system.
Finally, Narducci et al. (1) did not report their measurements of
the width of vegetation. Vegetations from infective endocarditis are
generally more thickened, coarse, and loose compared with lead
thrombi, which may be seen in as many as 30% of patients with in-
tracardiac leads (2). The width of the vegetation is, therefore, also an
important measurement to discriminate vegetation from thrombus.
The investigators should be congratulated for reporting a large
number of cases with transvenous lead extraction. However, their
results for comparison with TEE of diagnostic capability for
vegetation/mass have to be questioned because of the confounding
of ICE instruments and methodology insufﬁciency.*Jian-Fang Ren, MD
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We thank Drs. Ren, Supple, and Marchlinski for their interest in
our study (1) and for their thoughtful comments. The equipment
used for intracardiac echocardiography (ICE) consisted of an
Acuson Cypress system (Acuson-Siemens Inc., Mountain View,
California) and an AcuNav 10F (Siemens Medical Solutions
distributed by Biosense Webster, Diamond Bar, California) or
Soundstar (Biosense Webster) probe with 64 elements phased array
multifrequency transducer. We also performed very few cases with
a Sequoia ultrasound system, although the majority of cases were
